<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Tissue Regenix Cites BioMedGPS SmartTRAK as Source

Posted by Susan Paquette on 7/17/17 8:00 AM

Tissue Regenix.jpgTissue Regenix cited BioMedGPS SmartTRAK as a source when compiling their Corporate Overview for presentation at the Jeffries Healthcare Conference.

Tissue Regenix, founded in 2006 as a spin out of Leeds University in the UK, was established to commercialize academic research in regenerative medicine. Utilizing its unique dCell technology the Company develops and commercializes biocompatible acellular scaffolds derived from xenogenic and allogenic sources for wound care, orthopedic surgery and cardiovascular applications.

Subscribe to Blog

Topics: Your SmartTRAK News

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts